NCT04100733View on ClinicalTrials.gov

Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor

NAActive, not recruitingINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2027

Conditions
Non-muscle Invasive Bladder CancerUrinary Biomarker
Interventions
DIAGNOSTIC_TEST

Xpert Bladder Cancer Monitor

Xpert Bladder Cancer Monitor detects mRNA fragments from 5 genes frequently overexpressed in non-muscle invasive bladder cancer.

DIAGNOSTIC_TEST

Flexible cystoscopy (WL/NBI) and urinary cytology

Adhering to current danish guidelines for follow-up of non-muscle invasive bladder cancer.

Trial Locations (3)

7500

Hospital of West Jutland, Holstebro

8200

Aarhus University Hospital, Århus N

Unknown

Zealand University Hospital, Roskilde

Sponsors

Collaborators (1)

Cepheid
All Listed Sponsors
collaborator

Cepheid

INDUSTRY

lead

Jørgen Bjerggaard Jensen

OTHER